KP Tissue Inc
TSX:KPT
KP Tissue Inc
TSX:KPT
Price:
10.84
CAD
Market Closed
Market Cap:
CA$108.6m
Balance Sheet
Balance Sheet Decomposition
KP Tissue Inc
KP Tissue Inc
Balance Sheet Decomposition is not available for
KP Tissue Inc
KP Tissue Inc
Balance Sheet
KP Tissue Inc
KP Tissue Inc
Currency: CAD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Total Receivables |
0
|
2
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
2
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Long-Term Investments |
140
|
162
|
154
|
127
|
117
|
99
|
99
|
81
|
70
|
79
|
79
|
68
|
70
|
70
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
140
N/A
|
163
+17%
|
155
-5%
|
129
-17%
|
119
-8%
|
101
-15%
|
102
+0%
|
83
-18%
|
71
-14%
|
81
+13%
|
82
+1%
|
71
-14%
|
71
+1%
|
72
+0%
|
|
| Liabilities | |||||||||||||||
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
3
|
2
|
3
|
2
|
2
|
3
|
4
|
4
|
2
|
2
|
2
|
2
|
|
| Total Current Liabilities |
0
|
2
|
3
|
2
|
3
|
2
|
2
|
3
|
4
|
4
|
2
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
3
|
2
|
1
|
1
|
2
|
4
|
3
|
1
|
1
|
6
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
5
N/A
|
5
-10%
|
4
-17%
|
4
+10%
|
4
-2%
|
6
+33%
|
6
+5%
|
5
-15%
|
5
-3%
|
8
+58%
|
2
-71%
|
2
-20%
|
2
+0%
|
|
| Equity | |||||||||||||||
| Common Stock |
140
|
9
|
10
|
12
|
13
|
15
|
17
|
19
|
20
|
22
|
22
|
23
|
23
|
23
|
|
| Retained Earnings |
1
|
1
|
12
|
49
|
59
|
75
|
82
|
101
|
112
|
104
|
108
|
115
|
117
|
115
|
|
| Additional Paid In Capital |
0
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
145
|
|
| Other Equity |
0
|
3
|
8
|
18
|
16
|
12
|
16
|
14
|
13
|
13
|
15
|
16
|
19
|
17
|
|
| Total Equity |
140
N/A
|
158
+13%
|
151
-5%
|
125
-17%
|
115
-8%
|
97
-16%
|
96
-1%
|
77
-20%
|
66
-14%
|
76
+14%
|
74
-2%
|
68
-8%
|
70
+2%
|
70
+0%
|
|
| Total Liabilities & Equity |
140
N/A
|
163
+17%
|
155
-5%
|
129
-17%
|
119
-8%
|
101
-15%
|
102
+0%
|
83
-18%
|
71
-14%
|
81
+13%
|
82
+1%
|
71
-14%
|
71
+1%
|
72
+0%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
8
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
